Price Alert

Lumos Pharma Inc. (LUMO)

NASDAQ: LUMO · Real-Time Price · USD

4.34

0.00 (0.00%)

At close: Dec 11, 2024, 10:00 PM

Lumos Pharma Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Cash & Equivalents	13.52M	16.8M	23.18M	35.08M	35.56M	37.86M	44.04M	56.01M	73.67M	79.51M	86.76M	94.81M	100.65M	107.7M	114.1M
Short-Term Investments	n/a	n/a	n/a	999K	7.14M	12.99M	13.95M	11.35M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	n/a	n/a	-304K	-390K	-472K	-283K	n/a	-465K	n/a	n/a	n/a	n/a	n/a
Receivables	174K	168K	181K	210K	172K	233K	200K	223K	168K	149K	134K	128K	116K	125K	194K
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-128K	n/a	n/a	n/a
Other Current Assets	3.58M	3.92M	4.18M	3.75M	4.58M	4.9M	5.07M	4.43M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Assets	17.27M	20.89M	27.54M	40.03M	47.45M	55.98M	63.25M	72.01M	78.83M	84.99M	92.64M	99.68M	105.75M	113.48M	119.6M
Property-Plant & Equipment	187K	463K	534K	603K	304K	390K	472K	283K	377K	465K	545K	635K	711K	793K	461K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	187K	463K	534K	603K	304K	390K	472K	283K	377K	465K	545K	635K	711K	793K	461K
Total Assets	17.46M	21.36M	28.08M	40.64M	47.75M	56.37M	63.73M	72.29M	79.21M	85.45M	93.19M	100.31M	106.47M	114.27M	120.06M
Account Payables	1.46M	337K	569K	890K	488K	279K	837K	275K	710K	854K	1.8M	612K	149K	312K	357K
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-294K	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	304K	n/a	282K	126K	179K	232K	n/a	294K	320K	345K	352K	349K	348K	261K
Other Current Liabilities	4.92M	2.2M	1.8M	3.19M	2.68M	3.47M	2.1M	2.47M	2.3M	1.83M	1.27M	2.46M	-349K	-348K	-261K
Total Current Liabilities	6.5M	4.93M	4.41M	7.03M	6.12M	6.54M	5.02M	6.71M	5.48M	4.83M	5.24M	5.13M	6.05M	6.78M	4.98M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	6M	6M	6M	6M	6M	6M	6M	n/a	6M	6M	6M	6M	6M	6M	6M
Total Long-Term Liabilities	6.04M	6.14M	6.22M	6.3M	6.14M	6.17M	6.19M	6M	6.02M	6.08M	6.13M	6.21M	6.29M	6.37M	6.11M
Total Liabilities	12.55M	11.08M	10.64M	13.33M	12.26M	12.71M	11.21M	12.71M	11.5M	10.91M	11.37M	11.34M	12.34M	13.15M	11.09M
Total Debt	172K	6.45M	6.52M	6.58M	269K	346K	421K	233K	313K	395K	476K	557K	637K	718K	367K
Common Stock	86K	81K	81K	81K	79K	80K	81K	82K	83K	83K	83K	83K	83K	83K	83K
Retained Earnings	-186.98M	-179.51M	-171.96M	-161.52M	-152.06M	-143.76M	-134.83M	-127.48M	-119.24M	-111.98M	-104.14M	-96.42M	-90.78M	-83.29M	-74.62M
Comprehensive Income	n/a	-0.00	0.00	-0.00	-4K	-11K	-5K	-9K	-0.00	0.00	0.00	0.00	-0.00	0.00	-0.00
Shareholders Equity	4.91M	10.28M	17.44M	27.3M	35.49M	43.66M	52.52M	59.58M	67.71M	74.55M	81.82M	88.98M	94.12M	101.12M	108.97M
Total Investments	n/a	n/a	n/a	999K	7.14M	12.99M	13.95M	11.35M	n/a	n/a	n/a	n/a	n/a	n/a	n/a